Utility of melatonin to treat surgical stress after major vascular surgery - A safety study

Bülent Kücükakin, Jens Lykkesfeldt, Hans Jørgen Nielsen, Russel J Reiter, Jacob Rosenberg, Ismail Gögenur

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Surgery for abdominal aortic aneurysm is associated with elevated oxidative stress. As an antioxidant in animal and human studies, melatonin has the potential of ameliorating some of this oxidative stress, but melatonin has never been administered to adults during surgery for the purpose of reducing oxidative damage. The aim of this pilot study was to evaluate the safety of various doses of melatonin administered during or after surgery and to monitor the changes in biomarkers of oxidative stress and inflammation during the pre-, intra-, and postoperative period. Six patients undergoing aortic surgery received 10 (n = 2), 30 (n = 2) or 60 (n = 2) mg melatonin intravenously in the intraoperative phase and 10 mg orally for three nights after surgery. Patients were monitored for hemodynamic parameters during and after surgery. Any unexpected events during the hospitalization were registered. Blood samples were collected preoperatively and at 5 min, 6 hr and 24 hr after clamp removal or after re-circulation of the first leg and the samples were analyzed for malondialdehyde (MDA), ascorbic acid (AA), dehydroascorbic acid (DHA), and interleukin-6 (IL-6). Troponin I (TpI) and C-reactive protein (CRP) were also measured for 4 days after surgery. Melatonin administration did not change hemodynamic parameters (mean arterial pressure or pulse rate) during surgery (P = 0.499 and 0.149, respectively), but oxidative stress parameters (MDA and AA) decreased significantly (P = 0.014 and 0.001, respectively). There was a significant increase in the inflammatory parameters (IL-6 and CRP) (P = 0.001 and 0.001, respectively) and an increase in TpI (P = 0.009) as a consequence of surgery. These were not influenced by melatonin treatment. Treatment of patients undergoing major aortic surgery with melatonin intravenously up to 60 mg in the intraoperative phase was safe and without complications. Melatonin may decrease oxidative damage resulting from surgery, but randomized clinical trials are required before definitive conclusions can be drawn regarding the clinical benefit of melatonin in surgical situations.

Original languageEnglish (US)
Pages (from-to)426-431
Number of pages6
JournalJournal of Pineal Research
Volume44
Issue number4
DOIs
StatePublished - May 2008

Fingerprint

Melatonin
Blood Vessels
Safety
Oxidative Stress
Troponin I
Malondialdehyde
C-Reactive Protein
Ascorbic Acid
Interleukin-6
Hemodynamics
Intraoperative Period
Dehydroascorbic Acid
Troponin C
Abdominal Aortic Aneurysm
Ambulatory Surgical Procedures
Postoperative Period
Leg
Arterial Pressure
Hospitalization
Randomized Controlled Trials

Keywords

  • Abdominal aortic aneurysm repair
  • Ischemic-reperfusion injury
  • Malondialdehyde
  • Melatonin
  • Oxidative stress
  • Safety

ASJC Scopus subject areas

  • Endocrinology

Cite this

Utility of melatonin to treat surgical stress after major vascular surgery - A safety study. / Kücükakin, Bülent; Lykkesfeldt, Jens; Nielsen, Hans Jørgen; Reiter, Russel J; Rosenberg, Jacob; Gögenur, Ismail.

In: Journal of Pineal Research, Vol. 44, No. 4, 05.2008, p. 426-431.

Research output: Contribution to journalArticle

Kücükakin, Bülent ; Lykkesfeldt, Jens ; Nielsen, Hans Jørgen ; Reiter, Russel J ; Rosenberg, Jacob ; Gögenur, Ismail. / Utility of melatonin to treat surgical stress after major vascular surgery - A safety study. In: Journal of Pineal Research. 2008 ; Vol. 44, No. 4. pp. 426-431.
@article{002cf08272c14ee2aeb72471450ab056,
title = "Utility of melatonin to treat surgical stress after major vascular surgery - A safety study",
abstract = "Surgery for abdominal aortic aneurysm is associated with elevated oxidative stress. As an antioxidant in animal and human studies, melatonin has the potential of ameliorating some of this oxidative stress, but melatonin has never been administered to adults during surgery for the purpose of reducing oxidative damage. The aim of this pilot study was to evaluate the safety of various doses of melatonin administered during or after surgery and to monitor the changes in biomarkers of oxidative stress and inflammation during the pre-, intra-, and postoperative period. Six patients undergoing aortic surgery received 10 (n = 2), 30 (n = 2) or 60 (n = 2) mg melatonin intravenously in the intraoperative phase and 10 mg orally for three nights after surgery. Patients were monitored for hemodynamic parameters during and after surgery. Any unexpected events during the hospitalization were registered. Blood samples were collected preoperatively and at 5 min, 6 hr and 24 hr after clamp removal or after re-circulation of the first leg and the samples were analyzed for malondialdehyde (MDA), ascorbic acid (AA), dehydroascorbic acid (DHA), and interleukin-6 (IL-6). Troponin I (TpI) and C-reactive protein (CRP) were also measured for 4 days after surgery. Melatonin administration did not change hemodynamic parameters (mean arterial pressure or pulse rate) during surgery (P = 0.499 and 0.149, respectively), but oxidative stress parameters (MDA and AA) decreased significantly (P = 0.014 and 0.001, respectively). There was a significant increase in the inflammatory parameters (IL-6 and CRP) (P = 0.001 and 0.001, respectively) and an increase in TpI (P = 0.009) as a consequence of surgery. These were not influenced by melatonin treatment. Treatment of patients undergoing major aortic surgery with melatonin intravenously up to 60 mg in the intraoperative phase was safe and without complications. Melatonin may decrease oxidative damage resulting from surgery, but randomized clinical trials are required before definitive conclusions can be drawn regarding the clinical benefit of melatonin in surgical situations.",
keywords = "Abdominal aortic aneurysm repair, Ischemic-reperfusion injury, Malondialdehyde, Melatonin, Oxidative stress, Safety",
author = "B{\"u}lent K{\"u}c{\"u}kakin and Jens Lykkesfeldt and Nielsen, {Hans J{\o}rgen} and Reiter, {Russel J} and Jacob Rosenberg and Ismail G{\"o}genur",
year = "2008",
month = "5",
doi = "10.1111/j.1600-079X.2007.00545.x",
language = "English (US)",
volume = "44",
pages = "426--431",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Utility of melatonin to treat surgical stress after major vascular surgery - A safety study

AU - Kücükakin, Bülent

AU - Lykkesfeldt, Jens

AU - Nielsen, Hans Jørgen

AU - Reiter, Russel J

AU - Rosenberg, Jacob

AU - Gögenur, Ismail

PY - 2008/5

Y1 - 2008/5

N2 - Surgery for abdominal aortic aneurysm is associated with elevated oxidative stress. As an antioxidant in animal and human studies, melatonin has the potential of ameliorating some of this oxidative stress, but melatonin has never been administered to adults during surgery for the purpose of reducing oxidative damage. The aim of this pilot study was to evaluate the safety of various doses of melatonin administered during or after surgery and to monitor the changes in biomarkers of oxidative stress and inflammation during the pre-, intra-, and postoperative period. Six patients undergoing aortic surgery received 10 (n = 2), 30 (n = 2) or 60 (n = 2) mg melatonin intravenously in the intraoperative phase and 10 mg orally for three nights after surgery. Patients were monitored for hemodynamic parameters during and after surgery. Any unexpected events during the hospitalization were registered. Blood samples were collected preoperatively and at 5 min, 6 hr and 24 hr after clamp removal or after re-circulation of the first leg and the samples were analyzed for malondialdehyde (MDA), ascorbic acid (AA), dehydroascorbic acid (DHA), and interleukin-6 (IL-6). Troponin I (TpI) and C-reactive protein (CRP) were also measured for 4 days after surgery. Melatonin administration did not change hemodynamic parameters (mean arterial pressure or pulse rate) during surgery (P = 0.499 and 0.149, respectively), but oxidative stress parameters (MDA and AA) decreased significantly (P = 0.014 and 0.001, respectively). There was a significant increase in the inflammatory parameters (IL-6 and CRP) (P = 0.001 and 0.001, respectively) and an increase in TpI (P = 0.009) as a consequence of surgery. These were not influenced by melatonin treatment. Treatment of patients undergoing major aortic surgery with melatonin intravenously up to 60 mg in the intraoperative phase was safe and without complications. Melatonin may decrease oxidative damage resulting from surgery, but randomized clinical trials are required before definitive conclusions can be drawn regarding the clinical benefit of melatonin in surgical situations.

AB - Surgery for abdominal aortic aneurysm is associated with elevated oxidative stress. As an antioxidant in animal and human studies, melatonin has the potential of ameliorating some of this oxidative stress, but melatonin has never been administered to adults during surgery for the purpose of reducing oxidative damage. The aim of this pilot study was to evaluate the safety of various doses of melatonin administered during or after surgery and to monitor the changes in biomarkers of oxidative stress and inflammation during the pre-, intra-, and postoperative period. Six patients undergoing aortic surgery received 10 (n = 2), 30 (n = 2) or 60 (n = 2) mg melatonin intravenously in the intraoperative phase and 10 mg orally for three nights after surgery. Patients were monitored for hemodynamic parameters during and after surgery. Any unexpected events during the hospitalization were registered. Blood samples were collected preoperatively and at 5 min, 6 hr and 24 hr after clamp removal or after re-circulation of the first leg and the samples were analyzed for malondialdehyde (MDA), ascorbic acid (AA), dehydroascorbic acid (DHA), and interleukin-6 (IL-6). Troponin I (TpI) and C-reactive protein (CRP) were also measured for 4 days after surgery. Melatonin administration did not change hemodynamic parameters (mean arterial pressure or pulse rate) during surgery (P = 0.499 and 0.149, respectively), but oxidative stress parameters (MDA and AA) decreased significantly (P = 0.014 and 0.001, respectively). There was a significant increase in the inflammatory parameters (IL-6 and CRP) (P = 0.001 and 0.001, respectively) and an increase in TpI (P = 0.009) as a consequence of surgery. These were not influenced by melatonin treatment. Treatment of patients undergoing major aortic surgery with melatonin intravenously up to 60 mg in the intraoperative phase was safe and without complications. Melatonin may decrease oxidative damage resulting from surgery, but randomized clinical trials are required before definitive conclusions can be drawn regarding the clinical benefit of melatonin in surgical situations.

KW - Abdominal aortic aneurysm repair

KW - Ischemic-reperfusion injury

KW - Malondialdehyde

KW - Melatonin

KW - Oxidative stress

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=42149103974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149103974&partnerID=8YFLogxK

U2 - 10.1111/j.1600-079X.2007.00545.x

DO - 10.1111/j.1600-079X.2007.00545.x

M3 - Article

C2 - 18205732

AN - SCOPUS:42149103974

VL - 44

SP - 426

EP - 431

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 4

ER -